Predictors of Return to Work During 3 Years After Start of First Tumor Necrosis Factor Antagonist in a National Cohort of Biologics-Treated Patients with Rheumatoid Arthritis.

被引：0
|
作者：
Olofsson, Tor [1 ]
Petersson, Ingemar F. [2 ]
Eriksson, Jonas [3 ]
Englund, Martin [2 ]
Geborek, Pierre [1 ]
Jacobsson, Lennart T. H. [4 ]
Askling, Johan [3 ]
Neovius, Martin [3 ]
机构：
[1] Lund Univ, Rheumatol Sect, Dept Clin Sci Lund, Lund, Sweden
[2] Lund Univ, Dept Orthoped, Lund, Sweden
[3] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden
[4] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
826
引用
收藏
页码：S359 / S360
页数：2
相关论文
共 50 条
  • [1] Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort
    Olofsson, Tor
    Petersson, Ingemar F.
    Eriksson, Jonas K.
    Englund, Martin
    Simard, Julia F.
    Nilsson, Jan-Ake
    Geborek, Pierre
    Jacobsson, Lennart T. H.
    Askling, Johan
    Neovius, Martin
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (05) : 845 - 853
  • [2] Predictors of Work Disability During the First 3 Years After Diagnosis in a National Rheumatoid Arthritis Inception Cohort.
    Olofsson, Tor
    Petersson, Ingemar F.
    Eriksson, Jonas
    Englund, Martin
    Simard, Julia F.
    Geborek, Pierre
    Jacobsson, Lennart T. H.
    Askling, Johan
    Neovius, Martin
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S984 - S984
  • [3] Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis.
    Setoguchi, S.
    Schneeweiss, S.
    Avorn, J.
    Katz, J. N.
    Weinblatt, M. E.
    Levin, R.
    Solomon, D. H.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S38 - S38
  • [4] Serum erytropoietin in patients with rheumatoid arthritis treated with infliximab, tumor necrosis factor-alpha antagonist
    Widuchowska, M
    Wiecek, A
    Kucharz, EJ
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 302 - 302
  • [5] The Risk of Lymphoma in Patients Receiving Anti-Tumor Necrosis Factor Therapy for Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register - Rheumatoid Arthritis.
    Mercer, Louise K.
    Lunt, Mark
    Low, Audrey S.
    Galloway, James B.
    Watson, Kath
    Dixon, William G.
    Symmons, Deborah P.
    Hyrich, Kimme L.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S680 - S680
  • [6] Direct Comparative Effectiveness Among 3 Anti-Tumor Necrosis Factor Biologics in a Real-Life Cohort of Patients With Rheumatoid Arthritis
    Santos-Moreno, Pedro
    Sanchez, Guillermo
    Gomez, Danny
    Bello-Gualtero, Juan
    Castro, Carlos
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (02) : 57 - 62
  • [7] Risk of Serious Infection and Malignancy in Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Biologics
    Thyagarajan, Veena
    Norman, Heather
    Enger, Cheryl
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 160 - 160
  • [8] The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry/Cohort Studies
    Ai, Jing-Wen
    Zhang, Shu
    Ruan, Qiao-Ling
    Yu, Yi-Qi
    Zhang, Bing-Yan
    Liu, Qi-Hui
    Zhang, Wen-Hong
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (12) : 2229 - 2237
  • [9] Mortality Rates in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors Drug-Specific Comparisons in the Swedish Biologics Register
    Simard, Julia F.
    Neovius, Martin
    Askling, Johan
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (11): : 3502 - 3510
  • [10] Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study
    Einarsson, Jon Thorkell
    Geborek, Pierre
    Saxne, Tore
    Kapetanovic, Meliha C.
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (05) : 741 - 748
12345